The Efficacy of Intravitreal Bevacizumab in Vitreous Hemorrhage of Diabetic Subjects

about

Intravitreal Bevacizumab in Vitreous Hemorrhage and Diabetes Mellitus.Intraocular Hemorrhage due to use of Sildenafil in a Patient with Diabetes

P2860

Q42292548-7B5AD570-D215-4618-B241-314217FBFDCF Q58597196-5D6EF51D-2031-4833-B6AD-D26C05B58868

P2860

The Efficacy of Intravitreal Bevacizumab in Vitreous Hemorrhage of Diabetic Subjects

Item

http://www.wikidata.org/entity/Q37545245

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 17 October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The Efficacy of Intravitreal Bevacizumab in Vitreous Hemorrhage of Diabetic Subjects

@en

The Efficacy of Intravitreal Bevacizumab in Vitreous Hemorrhage of Diabetic Subjects.

@nl

type

Item

label

The Efficacy of Intravitreal Bevacizumab in Vitreous Hemorrhage of Diabetic Subjects

@en

The Efficacy of Intravitreal Bevacizumab in Vitreous Hemorrhage of Diabetic Subjects.

@nl

prefLabel

The Efficacy of Intravitreal Bevacizumab in Vitreous Hemorrhage of Diabetic Subjects

@en

The Efficacy of Intravitreal Bevacizumab in Vitreous Hemorrhage of Diabetic Subjects.

@nl

P1476

The Efficacy of Intravitreal Bevacizumab in Vitreous Hemorrhage of Diabetic Subjects

@en

P2093

Ahmet Taylan Yazıcı

http://www.w3.org/2001/XMLSchema#string

Burcu Çelik

http://www.w3.org/2001/XMLSchema#string

Cengiz Alagöz

http://www.w3.org/2001/XMLSchema#string

Halil İbrahim Demirkale

http://www.w3.org/2001/XMLSchema#string

Muhittin Taşkapılı

http://www.w3.org/2001/XMLSchema#string

Murat Kocamaz

http://www.w3.org/2001/XMLSchema#string

Uğur Çiçek

http://www.w3.org/2001/XMLSchema#string

Yusuf Yıldırım

http://www.w3.org/2001/XMLSchema#string

Ökkeş Baz

http://www.w3.org/2001/XMLSchema#string

P2860

Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.

Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study).

Intravitreal bevacizumab (Avastin) prevention of panretinal photocoagulation-induced complications in patients with severe proliferative diabetic retinopathy.

Panretinal photocoagulation combined with intravitreal bevacizumab in high-risk proliferative diabetic retinopathy.

Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects

Panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab for high-risk proliferative diabetic retinopathy.

Retinopathy in a population-based study

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Randomized clinical trial evaluating intravitreal ranibizumab or saline for vitreous hemorrhage from proliferative diabetic retinopathy.

Evaluation of results 1 year following short-term use of ranibizumab for vitreous hemorrhage due to proliferative diabetic retinopathy.

P304

221-225

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4274/TJO.82542

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28058164

http://www.w3.org/2001/XMLSchema#string

P921

bevacizumab

P932

5200834

http://www.w3.org/2001/XMLSchema#string

The Efficacy of Intravitreal Bevacizumab in Vitreous Hemorrhage of Diabetic Subjects

about

P2860

P2860

The Efficacy of Intravitreal Bevacizumab in Vitreous Hemorrhage of Diabetic Subjects

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932